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Association between the site of brain injury and poststroke spasticity is poorly understood.The present study investigated whether
lesion analysis could document brain regions associated with the development of severe upper limb poststroke spasticity. A
retrospective analysis was conducted on 39 chronic stroke patients. Spasticity was assessed at the affected upper limb with
the modified Ashworth scale (shoulder, elbow, wrist, and fingers). Brain lesions were traced from magnetic resonance imaging
performed within the first 7 days after stroke and region of interest images were generated. The association between severe
upper limb spasticity (modified Ashworth scale ≥2) and lesion location was determined with the voxel-based lesion-symptom
mapping method implemented in MRIcro software. Colored maps representing the 𝑧 statistics were generated and overlaid onto
the automated anatomical labeling and the Johns Hopkins University white matter templates provided with MRIcron. Thalamic
nuclei were identified with the Talairach Daemon software. Injuries to the insula, the thalamus, the basal ganglia, and white matter
tracts (internal capsule, corona radiata, external capsule, and superior longitudinal fasciculus) were significantly associated with
severe upper limb poststroke spasticity. Further advances in our understanding of the neural correlates of spasticity may lead to
early targeted rehabilitation when key regions are damaged.
1. Introduction
Spasticity is characterized by a velocity-dependent increase
in muscle tone with exaggerated tendon jerks, resulting from
hyperexcitability of the stretch reflex [1]. It affects neuromotor
function after a lesion in the corticospinal [2] and accompa-
nying parapyramidal (corticoreticulospinal) pathways [2].
Poststroke spasticity (PSS) has a prevalence ranging from
4–27% in the early phase of illness (1–4 weeks after stroke) to
17–43% in the chronic one (>3 months) (no clear difference
between the upper and lower limbs, but a frequently higher
severity in the former) [2, 3]. Severe PSS [3] carries a heavy
burden, as it is associated with pain, decreased quality of life,
higher impairment, and disability [4].
Low Barthel Index (BI) score [5], marked paresis [3–6],
poststroke pain [6], and sensory deficits [3] were reported to
relate to the presence and severity of PSS [2], but the hetero-
geneousmeasures of spasticity and the variable findings from
previous studies limit their strength as early predictors. Stroke
locationwas consistently reported to play a role in upper limb
motor recovery [7], but its association with upper limb PSS is
unclear.
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Elucidating this point could enhance our understanding
of the neural circuitry involved in spasticity and help priori-
tizing prevention or early treatment in patients at high risk for
developing PSS.Thus, the aimof the current investigationwas
to determine the association between stroke lesion location
and severe upper limb PPS using brain voxel-based lesion-
symptom mapping (VLSM) procedures [8].
2. Materials and Methods
In this retrospective study, we recruited 116 adults, who
consecutively were referred to the Neurorehabilitation Unit
of the Azienda Ospedaliera Universitaria Integrata of Verona
(January 2011–December 2012) for the evaluation of a recent
stroke.
Inclusion criteria are as follows: first-ever unilateral isch-
emic stroke occurred 3–6 months earlier and high resolution
1.5 T anatomical magnetic resonance imaging (MRI) scans
were performed within the first 7 days after stroke with
T2-weighted fluid-attenuated inversion-recovery (FLAIR)
and diffusion-weighted imaging (DWI) sequences available.
Exclusion criteria are as follows: previous stroke, other neu-
rological disorders or musculoskeletal conditions that might
bias spasticity evaluation, and previous or current treatment
with antispastic drugs or therapies (e.g., botulinum toxin,
phenol block) that might influence spasticity. Patients were
treated according to the current stroke rehabilitation guide-
lines [9].
All patients gave their written consent for participation in
the study.Theprotocolwas carried out according to the decla-
ration of Helsinki and was approved by the Ethics Committee
of theDepartment ofNeurological andMovement Sciences of
Verona University.
2.1. Muscle Tone Assessment. Spasticity was assessed with
the modified Ashworth scale (MAS) [3, 10], which is a 6-
point scale grading the resistance of a relaxed limb to rapid
passive stretch (0: no increase inmuscle tone; 1: slight increase
in muscle tone manifested by a catch and release or by
minimal resistance at the end of the range of motion when
the affected part(s) is moved in flexion or extension; 1+: slight
increase in muscle tone manifested by a catch, followed by
minimal resistance throughout the remainder (less than half)
of the range of motion; 2: more marked increase in muscle
tone through most of the range of motion; 3: considerable
increase in muscle tone, passive movement difficulty; and
4: affected part(s) rigid in flexion or extension). Spasticity
evaluation at the affected arm included passive flexion and
extension movements of several joints with the patient in a
sitting position. We tested arm abductors/adductors, elbow
flexors/extensors, wrist flexors/extensors, and finger flexors.
Patients were divided into those with (SP+) and those
without (SP–) PSS, which was defined as MAS ≥ 2 for any
of the tested movements [3].
2.2. Lesion Tracing. Lesions were visually identified as having
altered FLAIR and DWI signal intensity compared to cor-
responding contralateral tissue. DWI sequences were used
when MRI was performed within the first 48 h after stroke
and FLAIR sequences when MRI was performed between
48 h and 7 days after stroke [11]. Lesion tracing was carried
out using the ch2bet anatomical brain template provided
with the MRIcro software (http://www.mricro.com/) and
region of interest (ROI) images were generated [8]. Fur-
thermore, ROI images of each patient were converted into
volume of interest (VOI) images using MRIcron software
(http://www.mricro.com/mricron). All lesionswere traced by
a trained image analyst and confirmed by an experienced
clinical neurologist, who was blind to all clinical data, except
for the side of hemiparesis.
Since the proportion of right and left hemisphere lesions
was not significantly different between the SP+ and SP−
groups, and to improve the power of the lesion overlays anal-
ysis, ROI images were transformed to the right hemisphere
[12]. We felt confident that this procedure would not affect
our results because previous studies suggested that lesion
laterality does not significantly influence PSS [3, 13, 14].
2.3. Lesion and Statistical Analysis. Association between
severe upper limb PSS and VOI images was analyzed with the
VLSMmethods implemented in the nonparametric mapping
(NPM) software included into the MRIcron software [8].
For statistical purposes, we considered severe PSS as
a binary variable (absent/present) according to a binary
images/binary behaviour design [8]. Voxels damaged in less
than 2% of patients were ignored.The nonparametric Lieber-
meister statistical analysis for binary data was used [8]. The
level of significance was 𝑃 < 0.05 and corrected for multiple
comparisons with the false discovery rate (FDR) threshold
(permutation thresholding was reported to be less sensitive
than FDR and consequently was not performed) [15].
Colored VLSM maps representing the 𝑧 statistics were
generated and overlaid onto the automated anatomical
labeling (AAL) and the Johns Hopkins University (JHU)
white matter templates provided with MRIcron software
[8]. Since MRIcron software does not provide informa-
tion on thalamic divisions, the Talairach Daemon software
(http://www.talairach.org/) was used for the overlaid analysis
of thalamic nuclei [16].
Pearson’s chi-squared test with Yates’ continuity correc-
tion was used for frequencies, Mann-Whitney 𝑈 test for
continuous variables, and Spearman rho for correlations for
the analysis of patients’ demographic clinical characteristics
(𝑃 < 0.05).
3. Results
Thirty-nine patients (24 males, 15 females; mean age 72.7
years) were included (Figure 1). Among the demographic
(age, sex) and clinical characteristics (mean time from stroke:
4.5 months; side of stroke: 21 left, 18 right; and location of
stroke: cortical 8, subcortical 12, and mixed 19), only stroke
severity was significantly greater in the SP+ group (European
Stroke Scale: SP+: 51.6±11.9, SP−: 88.6±8.7,𝑃 < 0.001; Table
1). Overlay of lesions for all patients is shown in Figure 2.
The number of MRI voxels involved by the stroke lesion
was significantly larger in the SP+ (63750.2±75764.1, median
33799) than in the SP− group (16298.4 ± 31706.7, median
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Table 1: Demographic, clinical, and MRI characteristics of the patients.
Patient Age Sex Time from stroke (mos) Stroke side Stroke location ESS score Lesion voxels (𝑛)
1, SP− 65 M 3 L Subcortical 83 90067
2, SP− 75 F 4 R Subcortical 80 898
3, SP− 80 F 5 L Subcortical 94 1584
4, SP− 75 F 6 L Subcortical 92 11377
5, SP− 67 F 3 R Mixed 81 4264
6, SP− 78 M 4 R Cortical 88 8171
7, SP− 83 M 5 L Mixed 81 3561
8, SP− 76 F 4 L Subcortical 97 4829
9, SP− 67 M 6 L Subcortical 81 3558
10, SP− 59 M 3 R Mixed 88 2455
11, SP− 63 F 4 R Mixed 80 44832
12, SP− 83 M 5 R Cortical 100 4264
13, SP− 68 M 6 L Mixed 83 6299
14, SP− 76 M 4 R Subcortical 84 2265
15, SP− 73 M 3 L Subcortical 96 44575
16, SP− 80 F 4 R Mixed 90 2544
17, SP− 69 M 6 L Cortical 70 1626
18, SP− 75 M 6 L Mixed 96 3985
19, SP− 66 M 5 L Subcortical 85 4829
20, SP− 64 M 5 L Cortical 100 8171
21, SP− 77 F 6 R Mixed 78 3561
22, SP− 85 F 4 R Cortical 100 130059
23, SP− 56 M 3 R Mixed 100 3177
24, SP− 60 F 4 L Mixed 100 210
25, SP+ 78 F 3 R Cortical 53 13645
26, SP+ 66 F 6 L Mixed 50 290752
27, SP+ 72 M 4 L Subcortical 64 110211
28, SP+ 75 M 4 R Cortical 62 73818
29, SP+ 69 M 3 L Mixed 61 60229
30, SP+ 67 M 3 L Mixed 58 33799
31, SP+ 73 M 4 R Mixed 51 3050
32, SP+ 74 M 6 R Cortical 61 3251
33, SP+ 78 F 5 L Mixed 58 145595
34, SP+ 79 F 5 L Mixed 30 89151
35, SP+ 66 F 6 L Subcortical 64 60102
36, SP+ 84 M 6 L Subcortical 53 26852
37, SP+ 76 M 3 R Mixed 34 17465
38, SP+ 80 M 4 R Mixed 30 10276
39, SP+ 78 M 5 R Mixed 45 18057
SP−: patient without severe spasticity; SP+: patient with severe spasticity; M: male; F: female; R: right; L: left; ESS: European Stroke Scale.
4124.5, 𝑃 = 0.001; Table 1). The lesion overlay of SP+ patients
and the VLSM revealed cerebral areas that were significantly
associated with severe PSS (Figure 3, Table 2).
Grey matter areas included the insula, the basal ganglia
(caudate, putamen, and pallidum), and the thalamus. White
matter tracts included the anterior and the posterior limb,
the retrolenticular part of the internal capsule, the anterior,
superior, and posterior corona radiate, the external capsule,
and the superior longitudinal fasciculus. The thalamic areas
significantly correlated with severe PSS corresponded to the
ventral posterior lateral nucleus in the Talairach atlas (Figure
3).
4. Discussion
The current study explored the anatomy underlying the
development of spasticity after stroke and documented that
damage to the insula, the thalamus, the basal ganglia, and
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Table 2: Brain regions associated with severe upper limb spasticity.
Region 𝑥 𝑦 𝑧 LB z max 𝑛 voxels
Insula 33 −7 20 3.784 12
Caudate 19 −13 21 3.827 56
Putamen 28 4 13 3.827 256
Pallidum 22 5 2 3.467 8
Thalamus 22 −17 4 3.467 65
Anterior limb of internal capsule 21 22 0 3.643 10
Posterior limb of internal capsule 26 −25 17 3.827 136
Retrolenticular part of internal capsule 23 −25 4 3.467 174
Anterior corona radiate 21 23 −1 3.643 149
Superior corona radiate 29 −6 19 4.188 226
Posterior corona radiate 26 −25 19 3.827 184
External capsule 28 4 13 3.827 159
Superior longitudinal fasciculus 30 −5 21 4.188 133
For each region, the Montreal Neurological Institute coordinates of the centre of mass are provided along with the maximum Liebermeister (LB) z statistic in
each cluster and the number (𝑛) of clustering voxels that survived the threshold of 𝑃 < 0.05, false discovery rate corrected.
Assessed for eligibility
(n = 116)
Eligible and assessed
(n = 39)
Excluded (n = 77)
Hemorrhagic stroke (n = 13)
Previous stroke (n = 19)
Bilateral stroke (n = 3)
No MRI within 7 days (n = 25)
Other neurological conditions (n = 9)
Musculoskeletal conditions (n = 8)
MRI = Magnetic resonance imaging
Figure 1: Flow diagram of the study.
many white matter tracts (internal capsule, corona radiata,
external capsule, and superior longitudinal fasciculus) is
associated with severe upper limb PSS.
We used a bottom-up lesion analysis, where patients were
grouped according to the presence of severe upper limb PSS
rather than lesion location. Our approach reduced the chance
of overlooking structures outside arbitrarily predefined ROIs
[7] and identified the critical areas with 1mm resolution.
It also overcame inaccuracies and uncertainties of previ-
ous anatomical studies, which defined lesion locations very
broadly by categorizing them as cortical versus subcortical,
or by computerized tomography scan instead of MRI [17].
Damage to corona radiata and internal capsule was previ-
ously found to predictmotor recovery after stroke, while pure
cortical lesions did not [7]. In keeping with previous data,
we did not find a correlation between severe PSS and corti-
cal strokes. Shared pathophysiological mechanisms between
spasticity and paresis explain why marked paresis [3–6] is a
good clinical predictor of severe PSS. Our findings however
indicate that severe PSS behaves differently from paresis, in
that the latter was found to correlate with the damage of the
posterior limb of the internal capsule [7], while we found the
former to be associated with lesions to different components
of the internal capsule and corona radiata. We may speculate
that the involvement of more primitive rubrospinal, reticu-
lospinal, and vestibulospinal motor control systems [7] may
have contributed to severe PSS in our patients.
This is the first report of a correlation between stroke
in the basal ganglia as well as in the external capsule and
severe PSS. The basal ganglia play a central role in motor
control. In that, they have bidirectional connections with the
primary motor cortex, premotor, and supplementary motor
areas through basal ganglia-thalamocortical circuits. Damage
to the basal ganglia might contribute to the spastic dystonia
component, which is common in patients with severe PSS. At
variance, the role of the external capsule is difficult to explain
on pathophysiological grounds, in that it contains fibres not
belonging to the motor system. An explanation for our find-
ing is that these subcortical structures (basal ganglia, external
capsule) turned out to be significantly associated with severe
PSS because they share the same vascular supply with the
internal capsule through the lenticulostriate branches of the
middle cerebral artery.Their role in the pathogenesis of severe
PSS should be better explored in future studies.
The ventral posterior lateral nucleus of the thalamus and
the insula turned out to be significantly associatedwith severe
PSS. This is the first report of the role of the ventral posterior
lateral nucleus and the insula in PSS, but our findings are in
keepingwith the association betweenPSS and sensory deficits
[3] and poststroke pain [6], both of which are common after
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Figure 2: Overlay of lesions for all patients.
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Figure 3: Statistical voxel-based lesion-symptom mapping. The nonparametric Liebermeister statistical analysis was used for the binary
variable severe poststroke spasticity. Here all voxels that survived a 1% false discovery rate cut-off threshold are reported. The yellow box
highlights the distribution of thalamic significant voxels, which corresponded to the ventral posterior nucleus in the Talairach atlas.
stroke involving these areas.They are also in accordance with
the view that pain may worsen spasticity [2].
The superior longitudinal fasciculus is the major dorsally
located fibre pathway linking parietal and frontal cortices [11].
This fasciculus has never been found to be associated with
PSS, but its role in spasticity is suggested by diffusion ten-
sor imaging evidence of its alteration in the spastic ataxia
of Charlevoix-Saguenay, a rare autosomal recessive neurode-
generative disorder [18].
Taken together, our data show a positive correlation
between severe PSS development and the degree of destruc-
tion or disorganization of the central sensorimotor system
[2]. This finding is in keeping with the significantly larger
number of lesioned voxels in the SP+ group andwith previous
reports showing that BI may predict PSS [5].
Limitations of our study are the small sample size, the
absence of correlation between clinical andMRI data, and the
use of a single subjective measure of spasticity. Furthermore,
the study design might have resulted in the exclusion of
patients with minor and less severe strokes (who usually are
not referred for neurorehabilitation consultancy), those with
most severe strokes (who die before 3–6months after stroke),
or older ones (in these patients computed tomography scan
is usually performed instead of MRI). However, the patients’
population included in the present study (intermediate stroke
severity) is the one where the prediction of PSS is clini-
cally more difficult and has more rehabilitative implications.
Finally, lesions were drawn on DWI for some subjects and
FLAIR for others because of the different timing of MRI
and the original brain scans were of lower resolution than
the high resolution T1 scans used in studies in chronic
stroke. However, the study was aimed at exploring whether
MRI early after stroke may help to predict PSS and, in this
phase, the extent of stroke cannot be reliably measured in T1
scans.
5. Conclusions
Our results have clinical implications, in the fact that they
may help early identification of those patients who carry
a higher risk of developing spasticity and may particularly
benefit from preventive and therapeutic strategies. Future
prospective larger studies including further clinical measures
are needed to strengthen our data and better explore predic-
tors of PSS thatmay lead to early targeted rehabilitation when
key regions are damaged.
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